Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer.

Linnea T OlssonAlina M HamiltonSarah C Van AlstenJennifer L LundTil StürmerHazel B NicholsKatherine E Reeder-HayesMelissa A Troester

Published in: Breast cancer research and treatment (2023)

While race was not strongly associated with chemotherapy receipt, younger age remains a strong predictor of chemotherapy receipt, even with adjustment for clinical factors and among women who receive genomic testing.

Keyphrases

locally advanced
polycystic ovary syndrome
squamous cell carcinoma
type diabetes
rectal cancer
radiation therapy
gene expression
metabolic syndrome
dna methylation
insulin resistance